www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Health

Drugs from overseas to get on fast track

By WANG XIAODONG | China Daily | Updated: 2017-07-14 07:50

Regulators, pharmaceutical companies, researchers will adopt global standards

China will continue to intensify international exchanges and cooperation in drug supervision to promote the domestic application of new medicines developed overseas to meet demand, China's top drug regulator said on Thursday.

The drug authorities will also encourage the domestic pharmaceutical industry to improve its capacity and competitiveness to promote the international visibility of Chinese medical and pharmaceutical products, Wu Zhen, vice-minister of the China Food and Drug Administration, said at the opening ceremony of the BRICS Meeting on Drug Regulatory Collaboration in Zhengzhou, Henan province.

On June 19, the administration announced it joined the International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, which focuses on guidelines for worldwide pharmaceutical development.

"Joining the council means the Chinese drug regulatory authorities, pharmaceutical industry and research and development institutes will gradually adopt internationally accepted standards and guidelines, actively participate in the formulation of international rules and promote quicker domestic application of new drugs developed in other countries," Wu said.

China is the second-largest market for pharmaceutical products in the world. Annual revenues of the pharmaceutical industry in China exceed 2.5 trillion yuan ($368.6 billion), and annual exports of pharmaceutical products exceed 13.5 billion yuan, Wu said.

"China has great pharmaceutical production capacity, so it can provide support to the health of the people in BRICS nations and other countries," he said.

BRICS comprises Brazil, Russia, India, China and South Africa.

The administration has adopted a series of reform measures on the review and approval of new drugs to accelerate approvals and meet the needs of domestic patients in recent years, Wu said.

The authorities will encourage medical institutions to give priority to new drugs that have proved effective and are reasonably priced, and support the inclusion of such new drugs in the list of drugs whose cost can be reimbursed by basic medical insurance programs, according to a draft regulation released by the administration in May.

Certain types of drugs and medical equipment already in use in other countries, such as those for curing rare diseases, can also gain priority approval for sale in the domestic market, the draft said.

As of the end of June, the administration had established routine work relations with drug regulatory authorities in 66 countries, and signed 42 agreements for bilateral cooperation with 28 countries and regions, said Yuan Lin, chief of the administration's international cooperation department.

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 成人做爰视频www在线观看 | 99国产福利视频区 | 99re热视频这里只精品 | 国产精品欧美一区二区在线看 | 91精品免费久久久久久久久 | 一级毛片免费视频观看 | 三级免费毛片 | 久久久久久久国产免费看 | 亚洲一区高清 | 热re66久久精品国产99热 | 亚洲精品高清视频 | 成人老司机深夜福利久久 | 在线免费观看毛片网站 | 亚洲综合在线另类色区奇米 | 国产精品久久久久一区二区三区 | 亚洲综合p | 亚洲精品成人一区二区 | 99久久国内精品成人免费 | 岛国午夜精品视频在线观看 | 久久久国产99久久国产首页 | 一本一道波多野结衣456 | 亚洲视频精品在线 | 国产片网站| 亚洲国产日韩a在线亚洲 | 视频综合网| 国产精品一区高清在线观看 | 国产成人啪精品视频免费软件 | 亚洲精品美女在线观看播放 | 亚洲毛片 | 精品国产三级 | 亚洲欧美影院 | 欧美成在线播放 | 精品国产午夜久久久久九九 | 网友自拍第一页 | 男人性天堂 | 国产成人精品亚洲77美色 | 欧美人成在线观看网站高清 | 国产高清专区 | 美女很黄很黄免费 | 欧美成人精品福利在线视频 | 美美女下面被cao爽 美女131爽爽爽做爰中文视频 |